Literature DB >> 31170403

Retinoic acid receptor gamma is targeted by microRNA-124 and inhibits neurite outgrowth.

Xiaohong Su1, Xi Gu1, Zhiduo Zhang1, Weipeng Li1, Xuemin Wang2.   

Abstract

During brain development, neurite outgrowth is required for brain development and is regulated by many factors. All-trans retinoic acid (RA) is an important regulator of cell growth and differentiation. MicroRNA-124 (miR-124), a brain-specific microRNA, has been implicated in stimulating neurite growth. In this study, we found that retinoic acid receptor gamma (RARG) expression was decreased, whereas miR-124 expression was increased during neural differentiation in mouse Neuroblastoma (N2a) Cells, P19 embryonal carcinoma (P19) cells, and mouse brain, as detected by immunoblotting or RT-qPCR. And we proved that miR-124 inhibited RARG expression by binding to the 3' UTR of RARG with a luciferase reporter assay. Upregulation of miR-124 (using miR-124 overexpressing plasmid and miR-124 mimic) led to a significant decrease in RARG protein in N2a cells and primary neurons. Therefore, we asked whether and how the miR-124/RARG axis regulates neuronal outgrowth, which is poorly understood. Strikingly, RARG knockdown by shRNA stimulated neurite growth in N2a cells and primary neurons, whereas RARG overexpression (without 3' UTR) inhibited neurite growth in N2a cells, P19 cells, and primary neurons. Furthermore, RARG knockdown could partially eliminate neurite outgrowth defects caused by the inhibitor of miR-124, while RARG overexpression could reverse the neurite outgrowth enhancing effect of the upregulation of miR-124. Collectively, the data reveal that miR-124/RARG axis is critical for neurite outgrowth. RARG emerges as a new target regulated by miR-124 that modulates neurite outgrowth, providing a novel context in which these two molecules function.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD437 (PubChem CID: 135411); Cell differentiation; Cytosine arabinoside (PubChem CID: 6253); Isoflurane (PubChem CID: 3763); L-Alanyl-l-glutamine (PubChem CID: 123935); MM11253 (PubChem CID: 10389639); MicroRNA; Mouse primary cortical neurons; Neurite outgrowth; Penicillin (PubChem CID: 5904); Puromycin (PubChem CID: 439530); Retinoic acid (PubChem CID: 444795); Retinoic acid receptor gamma; Streptomycin (PubChem CID: 19649); miR-124

Mesh:

Substances:

Year:  2019        PMID: 31170403     DOI: 10.1016/j.neuropharm.2019.05.034

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

2.  Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine.

Authors:  Mandakini B Singh; Christopher J Babigian; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2022-03-18       Impact factor: 5.250

3.  RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery.

Authors:  Rubin Hao; Bixi Sun; Lihua Yang; Chun Ma; Shuling Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  Non-Coding RNAs in Retinoic Acid as Differentiation and Disease Drivers.

Authors:  Carlos García-Padilla; Estefanía Lozano-Velasco; Carmen López-Sánchez; Virginio Garcia-Martínez; Amelia Aranega; Diego Franco
Journal:  Noncoding RNA       Date:  2021-02-17

5.  Chronic Administration of 13-cis-retinoic Acid Induces Depression-Like Behavior by Altering the Activity of Dentate Granule Cells.

Authors:  Xiao-Hong Su; Wei-Peng Li; Yi-Jie Wang; Jia Liu; Jun-Yu Liu; Ying Jiang; Fu-Hua Peng
Journal:  Neurotherapeutics       Date:  2021-12-10       Impact factor: 6.088

6.  Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach.

Authors:  Mohamed R Abdelaal; Esraa Ibrahim; Mohamed R Elnagar; Sameh H Soror; Hesham Haffez
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

7.  MicroRNA124-IL6R Mediates the Effect of Nicotine in Inflammatory Bowel Disease by Shifting Th1/Th2 Balance Toward Th1.

Authors:  Zhen Qin; Peng-Yuan Wang; Jing-Jing Wan; Yu Zhang; Jie Wei; Yang Sun; Xia Liu
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.